Panagora Asset Management’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-25,300
| Closed | -$4.48M | – | 2728 |
|
|
2020
Q1 | $4.48M | Sell |
25,300
-1,078
| -4% | -$203K | 0.03% | 377 |
|
|
2019
Q4 | $5.04M | Sell |
26,378
-30,165
| -53% | -$5.44M | 0.02% | 483 |
|
|
2019
Q3 | $9.52M | Sell |
56,543
-300,781
| -84% | -$49M | 0.04% | 339 |
|
|
2019
Q2 | $59.8M | Sell |
357,324
-280,295
| -44% | -$38.8M | 0.27% | 94 |
|
|
2019
Q1 | $93.4M | Sell |
637,619
-110,094
| -15% | -$16M | 0.42% | 54 |
|
|
2018
Q4 | $99.9M | Buy |
747,713
+279,374
| +60% | +$45.8M | 0.47% | 49 |
|
|
2018
Q3 | $89.2M | Buy |
468,339
+326,732
| +231% | +$60M | 0.34% | 73 |
|
|
2018
Q2 | $23.6M | Buy |
141,607
+113,325
| +401% | +$18.2M | 0.09% | 211 |
|
|
2018
Q1 | $4.76M | Sell |
28,282
-193,521
| -87% | -$32.5M | 0.02% | 548 |
|
|
2017
Q4 | $36.3M | Buy |
221,803
+31,253
| +16% | +$5.61M | 0.14% | 173 |
|
|
2017
Q3 | $39.1M | Buy |
190,550
+95,246
| +100% | +$22.2M | 0.15% | 143 |
|
|
2017
Q2 | $23.2M | Sell |
95,304
-153,856
| -62% | -$36.2M | 0.09% | 222 |
|
|
2017
Q1 | $59.5M | Sell |
249,160
-5,783
| -2% | -$1.35M | 0.25% | 97 |
|
|
2016
Q4 | $53.5M | Sell |
254,943
-2,361
| -0.9% | -$489K | 0.25% | 98 |
|
|
2016
Q3 | $59.3M | Buy |
257,304
+128,780
| +100% | +$31.5M | 0.28% | 77 |
|
|
2016
Q2 | $29.7M | Buy |
128,524
+19,750
| +18% | +$4.55M | 0.15% | 147 |
|
|
2016
Q1 | $29.2M | Sell |
108,774
-14,931
| -12% | -$4.27M | 0.14% | 153 |
|
|
2015
Q4 | $38.7M | Sell |
123,705
-4,639
| -4% | -$1.38M | 0.19% | 124 |
|
|
2015
Q3 | $34.9M | Buy |
128,344
+73,327
| +133% | +$22.5M | 0.18% | 135 |
|
|
2015
Q2 | $16.7M | Buy |
55,017
+32,417
| +143% | +$9.67M | 0.08% | 258 |
|
|
2015
Q1 | $6.73M | Buy |
22,600
+7,412
| +49% | +$2.11M | 0.03% | 418 |
|
|
2014
Q4 | $3.91M | Sell |
15,188
-1,927
| -11% | -$482K | 0.02% | 537 |
|
|
2014
Q3 | $4.13M | Buy |
17,115
+7,054
| +70% | +$1.58M | 0.02% | 538 |
|
|
2014
Q2 | $2.24M | Sell |
10,061
-5,436
| -35% | -$1.13M | 0.01% | 774 |
|
|
2014
Q1 | $3.19M | Buy |
15,497
+2,544
| +20% | +$504K | 0.02% | 695 |
|
|
2013
Q4 | $2.18M | Sell |
12,953
-19,858
| -61% | -$3.1M | 0.01% | 829 |
|
|
2013
Q3 | $4.72M | Buy |
32,811
+14,110
| +75% | +$1.88M | 0.02% | 533 |
|
|
2013
Q2 | $2.36M | Buy |
+18,701
| New | +$2.12M | 0.01% | 723 |
|
Other funds holding AGN
AJ
C
B
JJ
VFA
OPS
Panagora Asset Management's AGN Position: Q2 2020 in Review
Panagora Asset Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 25,300 shares — an estimated $4.48M sold.
Panagora Asset Management first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $99.9M in Q4 2018. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.
- Panagora Asset Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
- Panagora Asset Management sold 25,300 Allergan plc shares in Q2 2020, an estimated $4.48M.
- Panagora Asset Management first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
- Panagora Asset Management's Allergan plc position peaked at $99.9M in Q4 2018.
- 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.
Based on Panagora Asset Management's 13F filing for Q2 2020, filed 12 Aug 2020.